化合物CLP257
化合物CLP257 性质
| 沸点 | 473.3±55.0 °C(Predicted) |
|---|---|
| 密度 | 1.50±0.1 g/cm3(Predicted) |
| 储存条件 | 2-8°C |
| 溶解度 | 二甲基亚砜：20mg/mL |
| 酸度系数(pKa) | 7.23±0.40(Predicted) |
| 形态 | 粉末 |
| 颜色 | 白色至黄色至浅棕色 |
化合物CLP257 用途与合成方法
EC50: 616 nM (KCC2)
There is no change in [Cl − ] i in HEK293-cl cells when incubated with CLP257, indicating inactivity on NKCC1, KCC1, KCC3 or KCC4. Oocyte pre-incubation with CLP257 (200 nM) increases KCC2 transport activity by 61%, but causes no change in other CCCs. Functional, dose-dependent antagonism is also observed between CLP257 and the recently characterized KCC2 antagonist VU024055119. CLP257 (50 μM) provokes < 0.2% of the effect of 5 μM muscimol in CHO cells transduced with recombinant α1β2γ2 GABAA receptors, indicating negligible agonist activity of CLP257 on GABAA receptors.
CLP257 (100 mg/kg; intraperitoneal injection; adult male rats) treatment induced a significant increase in mechanical sensitivity.
| Animal Model: | Adult male rats (300 g) injected with Morphine |
| Dosage: | 100 mg/kg |
| Administration: | Intraperitoneal injection |
| Result: | Induced a significant increase in mechanical sensitivity. |
化合物CLP257 价格(试剂级)
| 更新日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
|---|---|---|---|---|---|
| 2024-11-08 | HY-110143 | 1 mg | 400 | ||
| 2024-11-08 | HY-110143 | 1181081-71-9 | 5mg | 1000 |
